Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Peptide Bonds

Peptide Bonds

A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Group Therapy

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Behavior Therapy

Behavior Therapy

Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diabetes and melanoma: Impact on prognosis and healthcare costs.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Same author

Health Promotion for Sun Protection: A Community Approach in a Mountain Setting.

High altitude medicine & biology·2026

Same author

Laser-based therapies in the management of non-melanoma skin cancers: a narrative review.

Lasers in medical science·2026

Same author

The Role of Laser Modalities in Melanoma Management: Critical Analysis of Local Control and Palliative Applications.

Cancers·2026

Same author

Clinicopathologic Features and Treatment Outcomes of Squamoid Eccrine Ductal Carcinoma: A Comprehensive Retrospective Series.

The American Journal of dermatopathology·2026

Same author

Impact on Quality of Life and Psychological Dimensions in Caregivers of Melanoma and Sarcoma Patients: A Scoping Review.

Cancers·2026

Search research articles

Related Experiment Video

Updated: Jan 31, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Peptides in melanoma therapy.

Simone Mocellin¹

¹Department of Oncological and Surgical Sciences, University of Padova, Via Giustiniani 2, 35128 Padova, Italy. simone.mocellin@unipd.it

Current Pharmaceutical Design

|January 13, 2012

Summary

Peptide vaccines show promise for melanoma treatment by stimulating T lymphocytes. However, clinical success is limited, necessitating further research into peptide design and immunotherapy strategies.

Area of Science:

Immunology
Oncology
Vaccine Development

Background:

Peptides from tumor-associated antigens can induce anti-melanoma immune responses in preclinical models.
Clinical vaccination with peptides often generates melanoma-specific T lymphocytes but rarely leads to significant tumor regression.

Purpose of the Study:

To review peptide design principles for melanoma vaccines.
To summarize clinical outcomes of peptide-based active immunotherapy for cutaneous melanoma.
To discuss immunological and methodological factors for improving peptide vaccine efficacy.

Main Methods:

Review of existing literature on peptide vaccine design and clinical trials for melanoma.
Analysis of immunological responses and clinical outcomes in patients treated with peptide vaccines.

More Related Videos

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Experiment Videos

Last Updated: Jan 31, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Discussion of challenges and potential solutions in developing effective peptide-based immunotherapy.

Main Results:

Peptide vaccination can induce T cell responses against melanoma.
Clinical efficacy of current peptide vaccines in treating cutaneous melanoma remains limited.
Several factors, including peptide selection and immunotherapy protocols, influence treatment outcomes.

Conclusions:

Peptide-based immunotherapy is a developing strategy for melanoma treatment.
Optimizing peptide design and addressing immunological hurdles are crucial for clinical success.
Further research is needed to enhance the effectiveness of peptide vaccines in melanoma patients.